DFE Pharma opens new CoE in Hyderabad to provide fast-track medicines formulation

DFE Pharma today opened its new “Closer to the Formulator” (C2F), a Centre of Excellence (CoE), in Hyderabad. C2F helps pharma companies to shorten the time from concept to finished commercial product through its expertise in all phases of pharma development, as per a statement from DFE Pharma.

The statement informed that KT Rama Rao, Cabinet Minister for IT, Industries and Commerce, Municipal Administration and Urban Departments, Telangana, endorsed the opening ceremony along with Jayesh Ranjan, IAS, Principal Secretary, Industries and Commerce, Government of Telangana; Shakthi Nagappan, Director, Lifesciences and Pharma, Government of Telangana, and DFE Pharma’s leadership team and senior representatives of leading pharma companies.

With the C2F centre, DFE Pharma aims to support global and local pharma and nutra companies to address these challenges, by developing robust formulations allowing for scale-up, high-speed production, and first-to-market launch, added the statement.

The 1200 square metres laboratory facilities of the C2F centre are equipped with the latest technology and staffed by experienced scientists. The services offered by this new centre, mainly focus on Oral Solid Dosage (OSD) forms and comprise a range of pre-registration work including development, scale-up and technology transfer. The capabilities also include efficiency projects like conversions from wet granulation to direct compression. The centre works with Active Pharmaceutical Ingredients (APIs), including innovative concepts as model APIs; and with a broad portfolio of all categories of excipients and their different grades, the statement further mentioned.

KT Rama Rao, said in the statement, “I’m delighted to inaugurate Closer to the Formulator (C2F), a Center of Excellence by DFE Pharma, in Hyderabad. I firmly believe that C2F will further strengthen the potential for growth and support offered by Genome Valley. The Government of Telangana will work with DFE Pharma to ensure that lifesciences companies in the state leverage from this facility.”